| Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment | |
| Zhou Dao-bin; Yu Li; Du Xin; Jin Jie; Cai Zhen; Chen Fangping; Ke Xiaoyan; Li Xiao; Wu Depei; Meng Fanyi | |
| 2015 | |
| 卷号 | 101期号:6页码:569-77 |
| ISSN号 | 1865-3774 |
| DOI | 10.1007/s12185-015-1771-7 |
| URL标识 | 查看原文 |
| 收录类别 | PUBMED |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/6388710 |
| 专题 | 中国医学科学院 北京协和医学院 |
| 推荐引用方式 GB/T 7714 | Zhou Dao-bin,Yu Li,Du Xin,et al. Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment[J],2015,101(6):569-77. |
| APA | Zhou Dao-bin.,Yu Li.,Du Xin.,Jin Jie.,Cai Zhen.,...&Hou Jian.(2015).Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment.,101(6),569-77. |
| MLA | Zhou Dao-bin,et al."Lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed or refractory multiple myeloma and renal impairment".101.6(2015):569-77. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论